Is menstrual blood loss a common cause of iron depletion in premenopausal women?

For premenopausal women, maintaining iron balance is a physiological challenge due to the recurring loss of blood during the menstrual cycle. This process is recognized as the most frequent cause of iron depletion in this demographic, as the body’s iron requirements often exceed dietary intake.

Clinical and effectiveness evidence

Large-scale clinical data and observational studies confirm that menstruation is a primary risk factor for iron deficiency.

• Prevalence and Risk: Research indicates that iron deficiency affects a significant portion of the premenopausal population, with some studies showing prevalence rates as high as 60–68% in high-risk groups, such as those with a history of iron deficiency. In contrast, postmenopausal women show significantly lower rates of depletion.
• Heavy Menstrual Bleeding (HMB): Approximately one-third of reproductive-age women experience HMB, which is a leading contributor to iron deficiency anemia. Women with HMB lose significantly more iron than the physiological average, often exhausting their iron stores (serum ferritin <15–30 μg/L).

Mechanistic explanations

The relationship between menstruation and iron depletion is driven by direct blood loss and hormonal influences on iron regulation.

• Direct Erythrocyte Loss: Iron is stored within hemoglobin in red blood cells. Normal menstruation results in a daily average iron loss of 0.5–2 mg. Over time, if dietary absorption does not compensate for this loss, total body iron stores are progressively depleted.
• Hepcidin Regulation: Emerging research suggests that the menstrual cycle influences hepcidin, the primary hormone regulating iron homeostasis. Fluctuations in hepcidin levels during the cycle can temporarily impair intestinal iron absorption, exacerbating the deficit created by physical blood loss.

Bottom line

Menstrual blood loss is a well-established and common cause of iron depletion in premenopausal women. The combination of direct iron loss through bleeding and cycle-related changes in iron absorption makes this population highly susceptible to deficiency, necessitating clinical monitoring of ferritin levels.